↓ Skip to main content

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Overview of attention for article published in Journal of Hematology & Oncology, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
policy
2 policy sources

Citations

dimensions_citation
177 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Published in
Journal of Hematology & Oncology, January 2014
DOI 10.1186/1756-8722-7-11
Pubmed ID
Authors

Bertrand Coiffier, Barbara Pro, H Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan Iyer, Andrei Shustov, Tina Nielsen, Jean Nichols, Julie Wolfson, Barbara Balser, Steven Horwitz

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Denmark 1 <1%
Unknown 119 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 17%
Other 15 12%
Student > Ph. D. Student 13 11%
Student > Doctoral Student 13 11%
Student > Postgraduate 10 8%
Other 23 19%
Unknown 26 21%
Readers by discipline Count As %
Medicine and Dentistry 52 43%
Agricultural and Biological Sciences 11 9%
Biochemistry, Genetics and Molecular Biology 7 6%
Nursing and Health Professions 3 2%
Computer Science 3 2%
Other 15 12%
Unknown 30 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#2,551,213
of 24,674,353 outputs
Outputs from Journal of Hematology & Oncology
#208
of 1,267 outputs
Outputs of similar age
#29,651
of 316,968 outputs
Outputs of similar age from Journal of Hematology & Oncology
#2
of 15 outputs
Altmetric has tracked 24,674,353 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,267 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,968 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.